Home › Head and Neck Squamous Cell Carcinoma › Wisconsin › La Crosse
Head and Neck Squamous Cell Carcinoma clinical trials in La Crosse, WI
3 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in and around La Crosse (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
RecruitingPhase 3
- Gundersen Lutheran Medical Center, La Crosse
- Mayo Clinic Health System-Franciscan Healthcare, La Crosse
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- Gundersen Lutheran Medical Center, La Crosse
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Gundersen Lutheran Medical Center, La Crosse
Head and Neck Squamous Cell Carcinoma trials in other cities
- Houston, TX47 studies
- Los Angeles, CA42 studies
- Boston, MA40 studies
- Nashville, TN39 studies
- New York City, NY39 studies
- St. Louis, MO28 studies
- Arlington, VA26 studies
- Philadelphia, PA26 studies
- Chicago, IL26 studies
- Atlanta, GA24 studies
- San Antonio, TX22 studies
- Pittsburgh, PA22 studies
Other studies in La Crosse
- Non-Small Cell Lung Cancer10 studies
- Lung Cancer9 studies
- Breast Cancer6 studies
- Acute Myeloid Leukemia6 studies
- Multiple Myeloma4 studies
- Diffuse Large B-Cell Lymphoma3 studies
- Laryngeal Cancer3 studies
- Oral Cancer3 studies
- Endometrial Cancer3 studies
- Ovarian Cancer3 studies
- Melanoma3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.